The UNC93B1 expression level was higher in AML patients with older age (age > 60, p < 0.01, Figure 1F), non-M3 FAB classification (p < 0.05, Supplementary Figure S1A), especially M4/M5 FAB subtype (p < 0.001, Figure 1G), in which monocytes were prominent. Here, UNC93B1 is linked to acute myeloid leukemia.